Journal article

Rsx is a metatherian RNA with Xist-like properties in X-chromosome inactivation

Jennifer Grant, Shantha K Mahadevaiah, Pavel Khil, Mahesh N Sangrithi, Helene Royo, Janine Duckworth, John R McCarrey, John L VandeBerg, Marilyn B Renfree, Willie Taylor, Greg Elgar, R Daniel Camerini-Otero, Mike J Gilchrist, James MA Turner

NATURE | NATURE PUBLISHING GROUP | Published : 2012

University of Melbourne Researchers

Grants

Awarded by Medical Research Council (MRC)


Awarded by NIH


Awarded by New Zealand Foundation for Research, Science and Technology, Possum Biocontrol


Awarded by Australian National Health and Medical Research Council


Awarded by EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT


Awarded by EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT


Awarded by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES


Awarded by Medical Research Council


Funding Acknowledgements

We thank D. Bell and R. Lovell-Badge for advice on the characterisation of Rsx, J. Cloutier and G. Polikiewicz for help with germ-cell preparations and quantitative PCR, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Genomics core (National Institutes of Health, NIH) for RNA sequencing, A. Toth for the HORMAD1 antibody, the Biological and Procedural Services units at the National Institute for Medical Research (NIMR) for animal husbandry and Rsx transgenesis, and J. Cocquet, L. Reynard, H. Byers and members of the Turner and P. Burgoyne laboratories for reading of the manuscript. This work was supported by the Medical Research Council (MRC) (U117588498, U117597141, U117581331, U117597137), the NIH (HD60858), the Robert J. Kleberg Jr and Helen C. Kleberg Foundation, the New Zealand Foundation for Research, Science and Technology, Possum Biocontrol (C10X0501), the Australian National Health and Medical Research Council (1010453) and the NIDDK (NIH) Intramural Research Program.